Dis-Chem Pharmacies Management
Management criteria checks 2/4
Dis-Chem Pharmacies' CEO is Rui Morais, appointed in Jul 2023, has a tenure of less than a year. total yearly compensation is ZAR18.12M, comprised of 64.2% salary and 35.8% bonuses, including company stock and options. directly owns 0.99% of the company’s shares, worth ZAR261.59M. The average tenure of the management team and the board of directors is 1.8 years and 3.3 years respectively.
Key information
Rui Morais
Chief executive officer
R18.1m
Total compensation
| CEO salary percentage | 64.2% |
| CEO tenure | less than a year |
| CEO ownership | 1.0% |
| Management average tenure | 1.8yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around
Apr 17
Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly
Feb 26Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively
Dec 30If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity
Sep 07Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly
Aug 16Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends
Jul 31Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
May 09There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
Mar 29Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
Jan 14Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture
Nov 04Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate
Oct 04We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease
Sep 01Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
Jul 04A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)
Jun 21Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet
Jun 08The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts
May 25Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?
Feb 23Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings
Feb 08I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease
Dec 13Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality
Nov 09CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Aug 31 2023 | n/a | n/a | R899m |
| May 31 2023 | n/a | n/a | R949m |
| Feb 28 2023 | R18m | R12m | R1b |
| Nov 30 2022 | n/a | n/a | R1b |
| Aug 31 2022 | n/a | n/a | R1b |
| May 31 2022 | n/a | n/a | R946m |
| Feb 28 2022 | R14m | R11m | R853m |
| Nov 30 2021 | n/a | n/a | R815m |
| Aug 31 2021 | n/a | n/a | R776m |
| May 31 2021 | n/a | n/a | R722m |
| Feb 28 2021 | R6m | R6m | R669m |
| Nov 30 2020 | n/a | n/a | R655m |
| Aug 31 2020 | n/a | n/a | R641m |
| May 31 2020 | n/a | n/a | R620m |
| Feb 29 2020 | R6m | R6m | R598m |
| Nov 30 2019 | n/a | n/a | R573m |
| Aug 31 2019 | n/a | n/a | R549m |
| May 31 2019 | n/a | n/a | R634m |
| Feb 28 2019 | R5m | R5m | R719m |
| Nov 30 2018 | n/a | n/a | R718m |
| Aug 31 2018 | n/a | n/a | R718m |
| May 31 2018 | n/a | n/a | R701m |
| Feb 28 2018 | R7m | R5m | R684m |
Compensation vs Market: Rui's total compensation ($USD952.87K) is about average for companies of similar size in the ZA market ($USD961.57K).
Compensation vs Earnings: Rui's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Rui Morais (39 yo)
less than a year
Tenure
R18,122,000
Compensation
Mr. Rui Manuel Morais, CA(SA) has been the Chief Executive Officer at Dis-Chem Pharmacies Limited since July 01, 2023 and its Executive Director since August 13, 2012. He served as Chief Financial Officer...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | less than a year | R18.12m | 0.99% ZAR 261.6m | |
| CFO & Executive Director | less than a year | R3.43m | no data | |
| Executive Director | less than a year | R19.17m | no data | |
| Managing Director | 18.9yrs | R15.58m | no data | |
| Executive Director | 1.8yrs | R7.66m | 0.43% ZAR 115.1m | |
| Executive Director | 1.8yrs | R7.63m | 4.64% ZAR 1.2b | |
| Prescribed Officer | no data | R8.10m | no data | |
| Commercial Director | no data | R23.83m | 0.0045% ZAR 1.2m | |
| Prescribed Officer | no data | R4.48m | 0.0012% ZAR 307.1k | |
| Prescribed Officer | no data | R4.71m | no data | |
| Human Resources Director | no data | no data | no data | |
| Company Secretary | 3.1yrs | no data | no data |
1.8yrs
Average Tenure
66yo
Average Age
Experienced Management: DCP's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 11.7yrs | R18.12m | 0.99% ZAR 261.6m | |
| CFO & Executive Director | less than a year | R3.43m | no data | |
| Executive Director | 18.9yrs | R19.17m | no data | |
| Executive Director | 1.8yrs | R7.66m | 0.43% ZAR 115.1m | |
| Executive Director | 1.8yrs | R7.63m | 4.64% ZAR 1.2b | |
| Independent Non-Executive Chairman | 7.5yrs | R3.17m | 0.058% ZAR 15.4m | |
| Independent Non-Executive Director | 7.5yrs | R802.00k | 0.0095% ZAR 2.5m | |
| Independent Non-Executive Director | 7.5yrs | R598.00k | 0.019% ZAR 5.0m | |
| Independent Non-Executive Director | 3.3yrs | R598.00k | no data | |
| Non-Independent Non Executive Director | 2.4yrs | R484.00k | no data | |
| Independent Non-Executive Director | 1.8yrs | R423.00k | 0% ZAR 0 |
3.3yrs
Average Tenure
52.5yo
Average Age
Experienced Board: DCP's board of directors are considered experienced (3.3 years average tenure).